解放军医学杂志2017，Vol.42Issue(4)：354-357,4.DOI:10.11855/j.issn.0577-7402.2017.04.15
KL-6在间质性肺疾病诊治中的研究进展
Advances in the research on application of KL-6 in the diagnosis and treatment of interstitial lung disease
摘要
Abstract
Interstitial lung disease represents a group of diffuse pulmonary diseases that mainly affects pulmonary mesenchyme and alveolar spaces,resulting in loss of alveolar-capillary functions.It is also a common complication or an important factor that influences the prognosis of rheumatoid arthritis,dermatomyositis,systemic sclerosis.Searching for the biomarkers for the early diagnosis of the disease and/or indicative of the activity of the condition has been a subject of active investigations.KL-6,expressed on type Ⅱ pneumocytes,is seen as the most promising biomarker for the diagnosis of the disease.This review summarizes the recent researches about the use of KL-6 in the diagnosis and treatment of interstitial lung disease.关键词
间质性肺疾病/KL-6/诊断/预后Key words
interstitial lung disease/KL-6/diagnosis/prognosis分类
医药卫生引用本文复制引用
王冉冉,朱剑,张江林..KL-6在间质性肺疾病诊治中的研究进展[J].解放军医学杂志,2017,42(4):354-357,4.
